-The Hindu This is an agenda all political parties, and not just the Makkal Needhi Maiam, could incorporate in their manifestos In the context of the forthcoming State Assembly election in Tamil Nadu, the Makkal Needhi Maiam (MNM), led by veteran actor Kamal Haasan, has made an eye-catching election promise that is evidently targeted at a large constituency of voters — women who are full-time homemakers. The party has promised to recognise...

-Altnews.in The word ‘unprecedented’ only mildly captures the year 2020. The coronavirus pandemic did more than confine the privileged inside their homes and leave the destitute to their fates. It has changed the way we live. However, in a year mired with communal riots, student protests, civil rights movements and vilification of minorities, COVID-19 may not be the sole defining point for India. The past year is a reminder of mainstream media’s role...

-Livemint.com With a slew of development targets getting pushed back to at least 2030, what visions and goals are realistic? The year 2020 was bleak. And while the calendar changes, things may not change all that much until the public health benefits of a mass vaccination campaign kicks in. Meanwhile, it is important to take stock of where India’s development dreams stand and where the country can go from here. Many visions and...

-Siasat.com The unheard cries of hunger and starvation may not even be registered in the public consciousness. 2020 has been extremely challenging for people across the world. With COVID-19 cases spreading like wildfire and death tolls rising beyond prediction, the whole world came to a halt. India too has been in a similar situation for at least 9 months now. With an exponential rise in cases despite a strict lockdown, the state of...

-The Hindu They advise against Covaxin, say there is no proof of efficacy. Several experts have raised concern over the “hasty approval” granted to the COVID-19 vaccines despite the lack of adequate efficacy data. The Central Drugs Standard Control Organisation on Sunday accorded approval for restricted emergency use of the Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute of India (SII), and the indigenously developed vaccine Covaxin of Bharat Biotech. “I’m completely unaware...